Brief Summary
Type:
Lymphomas
Study Type:
Treatment
Phase:
II/III
ClinicalTrials.gov Identifier:
NCT05664217
Study #:
STUDY00149449
Start Date:
Jan 26, 2023
Full Details and Eligibility at clinicaltrials.gov
By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.
ClinicalTrials.gov ID: NCT05664217
View Complete Trial Details & Eligibility at ClinicalTrials.gov
